1. Abeliovich, A. & Gitler, A.D. (2016) Defects in trafficking bridge Parkinson’s disease pathology and genetics. Nature, 539, 207-216.
2. Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho, W.H., Castillo, P.E., Shinsky, N., Verdugo, J.M., Armanini, M., Ryan, A., Hynes, M., Phillips, H., Sulzer, D. & Rosenthal, A. (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron, 25, 239-252.
3. Abounit, S., Bousset, L., Loria, F., Zhu, S., de Chaumont, F., Pieri, L., Olivo-Marin, J.C., Melki, R. & Zurzolo, C. (2016) Tunneling nanotubes spread fibrillar alpha-synuclein by intercellular trafficking of lysosomes. EMBO J., 35, 2120-2138.
4. Aguzzi, A. & Rajendran, L. (2009) The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron, 64, 783-790.
5. Aharon-Peretz, J., Rosenbaum, H. & Gershoni-Baruch, R. (2004) Mutations in the glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews. N. Engl. J. Med., 351, 1972-1977.